Effect of dasatinib in a xenograft mouse model of canine histiocytic sarcoma and in vitro expression status of its potential target EPHA2

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2885|41|1|e45-e48

ISSN： 0140-7783

Source： JOURNAL OF VETERINARY PHARMACOLOGY & THERAPEUTICS, Vol.41, Iss.1, 2018-02, pp. : e45-e48

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evaluation of a combination chemotherapy protocol including lomustine and doxorubicin in canine histiocytic sarcoma

By  

JOURNAL OF SMALL ANIMAL PRACTICE, Vol. 56, Iss. 7, 2015-07 ,pp. : 425-429

John Wiley & Sons Inc

Access to resources Recommend Favorite

Epirubicin in the treatment of canine histiocytic sarcoma: sequential, alternating and rescue chemotherapy

By  

VETERINARY AND COMPARATIVE ONCOLOGY, Vol. 16, Iss. 1, 2018-03 ,pp. : E30-E37

John Wiley & Sons Inc

Access to resources Recommend Favorite

Hypercalcemia and parathyroid hormone‐related peptide expression in a dog with thyroid carcinoma and histiocytic sarcoma

By  

VETERINARY CLINICAL PATHOLOGY, Vol. 44, Iss. 2, 2015-06 ,pp. : 249-252

John Wiley & Sons Inc

Access to resources Recommend Favorite

The JAK2/STAT5 signaling pathway as a potential therapeutic target in canine mastocytoma

By  

VETERINARY AND COMPARATIVE ONCOLOGY, Vol. 16, Iss. 1, 2018-03 ,pp. : 55-68

John Wiley & Sons Inc

Access to resources Recommend Favorite

In vitro evaluation of the inhibitory effect of canine serum, canine fresh frozen plasma, freeze–thaw‐cycled plasma, and Solcoseryl™ on matrix metalloproteinases 2 and 9

By  

VETERINARY OPHTHALMOLOGY, Vol. 18, Iss. 3, 2015-05 ,pp. : 229-233

John Wiley & Sons Inc

Access to resources Recommend Favorite